Navigating the New Era of Pharma Compliance
An informative discussion with experts from Model N and IQVIA on what you need to know to stay ahead of regulatory changes and ensure continued compliance success in 2026.
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
The pharmaceutical landscape is entering a pivotal era of transformation. With the Inflation Reduction Act’s Maximum Fair Price (MFP) provisions coming into force, the HRSA 340B pilot redefining compliance benchmarks, and broader political and economic forces influencing pharma today, manufacturers must stay informed to prepare for revenue management impacts.
Join our panel of industry experts as they unpack the evolving policy landscape, executive actions, and market dynamics that are redefining pharma revenue management and compliance. This session will equip you with the insights and foresight needed to stay ahead of change.
We’ll discuss:
Gain clarity on where U.S. pharma policy is headed—and what steps your organization can take now to strengthen compliance, manage risk, and protect revenue integrity.
SVP Professional Services
Model N
Senior Principal, General Manager
IQVIA
Principal, Regulatory Compliance
IQVIA
Thank you for your interest in Model N. Please submit the form and our sales team will contact you within 24 hours.
We look forward to responding within one business day.